Breast Cancer Clinical Trial
Official title:
X-Ray Mammography Standard of Care Protocol
Background:
- X-ray mammography is the standard method for breast cancer screening. It is a
noninvasive test using x-rays to take pictures of breast tissue and detect any
abnormalities.
- The National Institutes of Health (NIH) Clinical Center has a breast imaging unit that
has been accredited by the American College of Radiology. To maintain accreditation, the
unit must recruit a certain number of women to have clinical mammograms each year in
order to maintain a high level of clinical skills and experience for the radiologists
and technologists.
Objectives:
- To create a state-of-the-art mammography unit at the NIH Clinical Center in order to
maintain American College of Radiology accreditation of the NIH breast imaging facility.
Eligibility:
- Women who are eligible for breast cancer screening because of family cancer history,
genetic test results, or previous instances of cancer. Participants may not be pregnant or
nursing at the time of the screening.
Design:
- Participants will provide a brief medical history on arrival at the NIH breast imaging
unit.
- Each participant will have a standard mammogram performed by a radiology technician.
- If the study is normal, participants will be told that no further evaluation will be
performed. If the results indicate a need for further imaging or tissue biopsy,
participants may elect to return to the care of their primary physician or to receive
further follow-up at the NIH Clinical Center.
Background:
A mammography facility in the Clinical Center of the National Institutes of Health (NIH) is
present in order to facilitate breast cancer research programs. The American College of
Radiology mammography accreditation program (1992 mammography Quality Standards Act (MQSA)
(1-3)) has established national standards for site accreditation for mammography. A key
requirement is to perform a minimum number of mammography examinations in the facility per
year. Minimum examination volumes are required to maintain expertise of the facility staff
for maintaining facility accreditation and compliance with Food and Drug Administration (FDA)
requirements.
Objectives:
Our primary aim is a protocol to maintain accreditation of the NIH breast imaging facility in
the Clinical Center of NIH.
Eligibility:
Women who are clinically indicated for screening mammography according to the National
Comprehensive Cancer Network (NCCN) guidelines (3) and the American Cancer Society
guidelines.
Design:
A standard of care protocol to perform standard clinically indicated mammography exams. We
are expected to recruit 1000 patient /year.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |